Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Biopolymers
|
March 27, 2003
Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies
Martin Béhé, Thomas M Behr
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2016
Targets and probes for non-invasive imaging of β-cells
Andreas Jodal, Roger Schibli, Martin Béhé
Wiener Klinische Wochenschrift
|
November 7, 2007
Imaging of gastrinomas by nuclear medicine methods
Martin Béhé, Martin Gotthardt, Thomas M Behr
Cancer Biotherapy & Radiopharmaceuticals
|
October 25, 2002
Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings
Thomas M Behr, Martin Béhé, George Sgouros
Cancers
|
June 2, 2021
Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin <sup>177</sup>Lu-PP-F11N
Nathalie M Grob, Roger Schibli, Martin Béhé, et al.
EJNMMI Research
|
November 19, 2013
Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties
Susanne Kossatz, Rosalba Mansi, Martin Béhé, et al.
Nuclear Medicine and Biology
|
June 14, 2025
Comparative evaluation of radiolabeled bombesin analogs [<sup>177</sup>Lu]Lu-AMBA and [<sup>177</sup>Lu]Lu-RM2 for targeting GRPR in glioblastoma model
Michal Grzmil, Muriel Aline Spahn, Philipp Berger, et al.
EJNMMI Research
|
July 10, 2014
A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
Andreas Jodal, Brigitte Lankat-Buttgereit, Maarten Brom, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2003
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives
Martin Béhé, Wolfgang Becker, Martin Gotthardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys
Martin Béhé, Gerald Kluge, Wolfgang Becker, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Biopolymers
|
March 27, 2003
Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies
Martin Béhé, Thomas M Behr
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2016
Targets and probes for non-invasive imaging of β-cells
Andreas Jodal, Roger Schibli, Martin Béhé
Wiener Klinische Wochenschrift
|
November 7, 2007
Imaging of gastrinomas by nuclear medicine methods
Martin Béhé, Martin Gotthardt, Thomas M Behr
Cancer Biotherapy & Radiopharmaceuticals
|
October 25, 2002
Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings
Thomas M Behr, Martin Béhé, George Sgouros
Cancers
|
June 2, 2021
Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin <sup>177</sup>Lu-PP-F11N
Nathalie M Grob, Roger Schibli, Martin Béhé, et al.
EJNMMI Research
|
November 19, 2013
Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties
Susanne Kossatz, Rosalba Mansi, Martin Béhé, et al.
Nuclear Medicine and Biology
|
June 14, 2025
Comparative evaluation of radiolabeled bombesin analogs [<sup>177</sup>Lu]Lu-AMBA and [<sup>177</sup>Lu]Lu-RM2 for targeting GRPR in glioblastoma model
Michal Grzmil, Muriel Aline Spahn, Philipp Berger, et al.
EJNMMI Research
|
July 10, 2014
A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
Andreas Jodal, Brigitte Lankat-Buttgereit, Maarten Brom, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2003
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives
Martin Béhé, Wolfgang Becker, Martin Gotthardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys
Martin Béhé, Gerald Kluge, Wolfgang Becker, et al.
Page
of 6